Scientific paper - Original scientific paper
Clinical Relevance of CD-68 Positive Cells in Normal Buccal Mucosa in Patients with Inflammatory Bowel Disease

Mijandrušić Sinčić, Brankica; Ilić Tomaš, Maja; Belušić-Gobić, Margita; Juretić, Mirna; Kovač, Dražen; Lekić, Andrica; Pernjak Pugel, Ester; Cerović, Robert; Štimac, Davor (2012)
Cite this document...

Mijandrušić Sinčić, B., Ilić Tomaš, M., Belušić Gobić, M., Juretić, M., Kovač, D., Lekić, A. ... Štimac, D. (2012). Clinical Relevance of CD-68 Positive Cells in Normal Buccal Mucosa in Patients with Inflammatory Bowel Disease. Croatica Chemica Acta, 85. (2), 171-176. doi: 10.5562/cca1779

Mijandrušić Sinčić, Brankica, et al. "Clinical Relevance of CD-68 Positive Cells in Normal Buccal Mucosa in Patients with Inflammatory Bowel Disease." Croatica Chemica Acta, vol. 85, no. 2, 2012, pp. 171-176. https://doi.org/10.5562/cca1779

Mijandrušić Sinčić, Brankica, Maja Ilić Tomaš, Margita Belušić Gobić, Mirna Juretić, Dražen Kovač, Andrica Lekić, Ester Pernjak Pugel, Robert Cerović and Davor Štimac. "Clinical Relevance of CD-68 Positive Cells in Normal Buccal Mucosa in Patients with Inflammatory Bowel Disease." Croatica Chemica Acta 85, no. 2 (2012): 171-176. https://doi.org/10.5562/cca1779

Mijandrušić Sinčić, B., et al. (2012) 'Clinical Relevance of CD-68 Positive Cells in Normal Buccal Mucosa in Patients with Inflammatory Bowel Disease', Croatica Chemica Acta, 85(2), pp. 171-176. doi: 10.5562/cca1779

Mijandrušić Sinčić B, Ilić Tomaš M, Belušić Gobić M, Juretić M, Kovač D, Lekić A, and sur.. Clinical Relevance of CD-68 Positive Cells in Normal Buccal Mucosa in Patients with Inflammatory Bowel Disease. Croatica Chemica Acta [Internet]. 2012 [cited 2019 August 25];85(2):171-176. doi: 10.5562/cca1779

B. Mijandrušić Sinčić, et al., "Clinical Relevance of CD-68 Positive Cells in Normal Buccal Mucosa in Patients with Inflammatory Bowel Disease", Croatica Chemica Acta, vol. 85, no. 2, pp. 171-176, 2012. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:064559. [Accessed: 25 August 2019]